Hexa Gene Hexosaminidase Alpha is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| infobox |
|---|
| HEXA Gene |
| Full Name |
| Symbol |
| Chromosomal Location |
| NCBI Gene ID |
| OMIM |
| Ensembl ID |
| UniProt |
| Associated Diseases |
The HEXA gene (Hexosaminidase Subunit Alpha) is located on chromosome 15q24.1 and encodes the alpha subunit of the lysosomal enzyme β-hexosaminidase A (Hex A). This enzyme is essential for the catabolism of GM2 ganglioside, a major ganglioside in neuronal membranes. Mutations in HEXA cause Tay-Sachs disease, a fatal lysosomal storage disorder characterized by progressive neurodegeneration. The gene is part of a family of hexosaminidase genes that also includes HEXB, with which it forms the heterodimeric Hex A enzyme.
The HEXA gene encodes the alpha subunit of the enzyme β-hexosaminidase A (Hex A), a lysosomal hydrolase essential for the catabolism of GM2 ganglioside and other glycoconjugates containing N-acetylhexosamines.
Hexosaminidase A is a heterodimer composed of an alpha (HEXA) and beta (HEXB) subunit. The enzyme functions within the acidic environment of lysosomes to hydrolyze:
The alpha subunit provides the catalytic site and is essential for Hex A activity. Mutations affecting the alpha subunit disrupt GM2 ganglioside catabolism, leading to accumulation in neurons.
Tay-Sachs disease is an autosomal recessive neurodegenerative disorder caused by HEXA mutations resulting in deficient Hex A activity. It is characterized by:
| Form | Age of Onset | Progression | Life Expectancy |
|---|---|---|---|
| Infantile | 3-6 months | Rapid | 2-4 years |
| Juvenile | 2-5 years | Intermediate | 10-15 years |
| Adult (LADB) | Puberty/adolescence | Slow | Variable |
A rare form caused by mutations in HEXA combined with deficiency of the GM2 activator protein, resulting in a similar phenotype to Tay-Sachs.
HEXA is expressed in most tissues with highest levels in:
In the brain, HEXA expression is essential for maintaining GM2 ganglioside turnover in neurons. The enzyme is synthesized in the ER and trafficked to lysosomes via mannose-6-phosphate receptors.
The study of Hexa Gene Hexosaminidase Alpha has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Gravel RA, et al. The GM2 gangliosidoses. In: Scriver CR, et al., eds. The Metabolic and Molecular Bases of Inherited Disease. 2001.
[2] Myerowitz R. Tay-Sachs disease-causing mutations and neutral variants in the HEXA gene. Human Mutation. 1997;9(3):195-208.
[3] Lemanski K, et al. Structure of human beta-hexosaminidase A. Journal of Biological Chemistry. 2003;278(18):16857-16862.
[4] Tifft CJ, et al. Mouse models of GM2 activator deficiency and Tay-Sachs disease. Proceedings of the National Academy of Sciences. 2009;106(14):5877-5882.
[5] Kakkis E, et al. Enzyme replacement therapy in a mouse model of Tay-Sachs disease. Nature Genetics. 1996;13(2):312-314.